| BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors (NCT07196111) | Guangzhou Bio-gene Technology Co., Ltd | 2025-10-10 |
| BCMA/GPRC5D CAR-T Therapy for Multiple Myeloma (NCT07196124) | Guangzhou Bio-gene Technology Co., Ltd | 2025-10-10 |
| Clinical Study on Evaluating the Safety and Effectiveness of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Third-line or Above Treatment (NCT07195617) | Guangzhou Bio-gene Technology Co., Ltd | 2025-10-10 |
| γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant (NCT07123662) | Guangzhou Bio-gene Technology Co., Ltd | 2025-09-01 |
| Clinical Study on the Safety and Efficacy of B7H3 CAR T Cells in Patients With B7H3 Positive Solid Tumors (NCT07152236) | Guangzhou Bio-gene Technology Co., Ltd | 2025-08-31 |
| Exosomes for Hairloss Treatment (NCT06932393) | Guangzhou Bio-gene Technology Co., Ltd | 2025-04-30 |
| Clinical Study on the Safety and Preliminary Efficacy of CDH17/GUCY2C CAR-T in the Treatment of Patients With Advanced Colorectal Cancer (NCT07152210) | Guangzhou Bio-gene Technology Co., Ltd | 2024-12-11 |
| Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia (NCT06813157) | Guangzhou Bio-gene Technology Co., Ltd | 2024-11-11 |
| Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (NCT06118788) | Guangzhou Bio-gene Technology Co., Ltd | 2024-03-07 |
| Clinical Study to Evaluate the Safety and Efficacy of CAR-T in the Treatment of Relapsed or Refractory Multiple Myeloma (NCT06068400) | Guangzhou Bio-gene Technology Co., Ltd | 2023-09-21 |
| Clinical Study on Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in the Treatment of Acute Myeloid Leukemia (NCT05943314) | Guangzhou Bio-gene Technology Co., Ltd | 2023-07-12 |
| A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma (NCT05909527) | Guangzhou Bio-gene Technology Co., Ltd | 2023-05-01 |